Lysine methylation promotes VEGFR-2 activation and angiogenesis

Science Signaling

Volumn 6, Issue 304, 2013, Pages

  Hartsough, Edward J ^a   Meyer, Rosana D ^a   Chitalia, Vipul ^b   Jiang, Yan ^a   Marquez, Victor E ^c   Zhdanova, Irina V ^a   Weinberg, Janice ^d   Costello, Catherine E ^a   Rahimi, Nader ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d University School of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARGININE; LYSINE; VASCULOTROPIN RECEPTOR 2;

ACETYLATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CELL FREE SYSTEM; CELL LYSATE; CONTROLLED STUDY; DIMERIZATION; EMBRYO; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; LIGAND BINDING; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS; STOICHIOMETRY; TANDEM MASS SPECTROMETRY; TUMOR GROWTH; UMBILICAL VEIN ENDOTHELIAL CELL; ZEBRA FISH;

ANIMALS; CELL LINE, TUMOR; HEK293 CELLS; HETEROGRAFTS; HUMANS; LYSINE; METHYLATION; MICE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84889238946     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004289     Document Type: Article

References (44)

1. M. A. Lemmon, J. Schlessinger, Cell signaling by receptor tyrosine kinases. Cell 141, 1117-1134 (2010).
2. W. A. Lim, T. Pawson, Phosphotyrosine signaling: Evolving a new cellular communication system. Cell 142, 661-667 (2010).
3. T. Hunter, The age of crosstalk: Phosphorylation, ubiquitination, and beyond. Mol. Cell 28, 730-738 (2007).
4. E. R. Eden, F. Huang, A. Sorkin, C. E. Futter, The role of EGF receptor ubiquitination in regulating its intracellular traffic. Traffic 13, 329-337 (2012).
5. S. Miyake, K. P. Mullane-Robinson, N. L. Lill, P. Douillard, H. Band, Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain. J. Biol. Chem. 274, 16619-16628 (1999).
6. R. D. Meyer, S. Srinivasan, A. J. Singh, J. E. Mahoney, K. R. Gharahassanlou, N. Rahimi, PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation. Mol. Cell. Biol. 31, 2010-2025 (2011).
7. S. Shaik, C. Nucera, H. Inuzuka, D. Gao, M. Garnaas, G. Frechette, L. Harris, L. Wan, H. Fukushima, A. Husain, V. Nose, G. Fadda, P. M. Sadow, W. Goessling, T. North, J. Lawler, W. Wei, SCF (β-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2. J. Exp. Med. 209, 1289-1307 (2012).
8. R. J. Klose, Y. Zhang, Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 8, 307-318 (2007).
9. J. K. Kurash, H. Lei, Q. Shen, W. L. Marston, B. W. Granda, H. Fan, D. Wall, E. Li, F. Gaudet, Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol. Cell 29, 392-400 (2008).
10. M. Jansson, S. T. Durant, E. C. Cho, S. Sheahan, M. Edelmann, B. Kessler, N. B. LaThangue, Arginine methylation regulates the p53 response. Nat. Cell Biol. 10, 1431-1439 (2008).
11. K. Yamagata, H. Daitoku, Y. Takahashi, K. Namiki, K. Hisatake, K. Kako, H. Mukai, Y. Kasuya, A. Fukamizu, Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol. Cell 32, 221-231 (2008).
12. J. M. Hsu, C. T. Chen, C. K. Chou, H. P. Kuo, L. Y. Li, C. Y. Lin, H. J. Lee, Y. N. Wang, M. Liu, H. W. Liao, B. Shi, C. C. Lai, M. T. Bedford, C. H. Tsai, M. C. Hung, Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nat. Cell Biol. 13, 174-181 (2011).
13. M. Kunizaki, R. Hamamoto, F. P. Silva, K. Yamaguchi, T. Nagayasu, M. Shibuya, Y. Nakamura, Y. Furukawa, The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. Cancer Res. 67, 10759-10765 (2007).
14. M. T. Bedford, S. G. Clarke, Protein arginine methylation in mammals: Who, what, and why. Mol. Cell 33, 1-13 (2009).
15. N. Rahimi, Vascular endothelial growth factor receptors: Molecular mechanisms of activation and therapeutic potentials. Exp. Eye Res. 83, 1005-1016 (2006).
16. N. Rahimi, V. Dayanir, K. Lashkari, Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J. Biol. Chem. 275, 16986-16992 (2000).
17. N. Rahimi, VEGFR-1 and VEGFR-2: Two non-identical twins with a unique physiognomy. Front. Biosci. 11, 818-829 (2006).
18. V. Dayanir, R. D. Meyer, K. Lashkari, N. Rahimi, Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J. Biol. Chem. 276, 17686-17692 (2001).
19. R. D. Meyer, C. Latz, N. Rahimi, Recruitment and activation of phospholipase Cγ1 by vascular endothelial growth factor receptor-2 are required for tubulogenesis and differentiation of endothelial cells. J. Biol. Chem. 278, 16347-16355 (2003).
20. R. D. Meyer, D. B. Sacks, N. Rahimi, IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis. PLOS One 3, e3848 (2008).
21. R. D. Meyer, V. Dayanir, F. Majnoun, N. Rahimi, The presence of a single tyrosine residue at the carboxyl domain of vascular endothelial growth factor receptor-2/FLK-1 regulates its autophosphorylation and activation of signaling molecules. J. Biol. Chem. 277, 27081-27087 (2002).
22. M. A. McTigue, J. A. Wickersham, C. Pinko, R. E. Showalter, C. V. Parast, A. Tempczyk-Russell, M. R. Gehring, B.Mroczkowski, C. C. Kan, J. E. Villafranca, K. Appelt, Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: A key enzyme in angiogenesis. Structure 7, 319-330 (1999).
23. M. D. Mostaqul Huq, P. Gupta, N. P. Tsai, R. White, M. G. Parker, L. N. Wei, Suppression of receptor interacting protein 140 repressive activity by protein arginine methylation. EMBO J. 25, 5094-5104 (2006).
24. M. Li, J. Luo, C. L. Brooks, W. Gu, Acetylation of p53 inhibits its ubiquitination by Mdm2. J. Biol. Chem. 277, 50607-50611 (2002).
25. H. Matsuzaki, H. Daitoku, M. Hatta, H. Aoyama, K. Yoshimochi, A. Fukamizu, Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 102, 11278-11283 (2005).
26. T. B. Miranda, C. C. Cortez, C. B. Yoo, G. Liang, M. Abe, T. K. Kelly, V. E. Marquez, P. A. Jones, DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol. Cancer Ther. 8, 1579-1588 (2009).
27. R. B. Pilz, G. Van den Berghe, G. R. Boss, Adenosine dialdehyde and nitrous oxide induce HL-60 differentiation. Blood 70, 1161-1164 (1987).
28. C. K. Tseng, V. E. Marquez, R. W. Fuller, B. M. Goldstein, D. R. Haines, H. McPherson, J. L. Parsons, W. M. Shannon, G. Arnett, M. Hollingshead, J. S. Driscoll, Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. J. Med. Chem. 32, 1442-1446 (1989).
29. P. Carmeliet, R. K. Jain, Angiogenesis in cancer and other diseases. Nature 407, 249-257 (2000).
30. N. R. Smith, D. Baker, N. H. James, K. Ratcliffe, M. Jenkins, S. E. Ashton, G. Sproat, R. Swann, N. Gray, A. Ryan, J. M. Jürgensmeier, C. Womack, Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers. Clin. Cancer Res. 16, 3548-3561 (2010).
31. L. Rydén, M. Stendahl, H. Jonsson, S. Emdin, N. O. Bengtsson, G. Landberg, Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response. Breast Cancer Res. Treat. 89, 135-143 (2005).
32. G. N. Serbedzija, E. Flynn, C. E. Willett, Zebrafish angiogenesis: A new model for drug screening. Angiogenesis 3, 353-359 (1999).
33. C. Tobia, G. De Sena, M. Presta, Zebrafish embryo, a tool to study tumor angiogenesis. Int. J. Dev. Biol. 55, 505-509 (2011).
34. K. Alitalo, P. Carmeliet, Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1, 219-227 (2002).
35. M. Tjwa, A. Luttun, M. Autiero, P. Carmeliet, VEGF and PlGF: Two pleiotropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res. 314, 5-14 (2003).
36. M. Shibuya, L. Claesson-Welsh, Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 312, 549-560 (2006).
37. S. Koch, S. Tugues, X. Li, L. Gualandi, L. Claesson-Welsh, Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 437, 169-183 (2011).
38. S. Srinivasan, R. D. Meyer, R. Lugo, N. Rahimi, Identification of PDCL3 as a novel chaperone protein involved in the generation of functional VEGFR receptor 2. J. Biol. Chem. 288, 23171-23181 (2013).
39. P. Carmeliet, Angiogenesis in health and disease. Nat. Med. 9, 653-660 (2003).
40. P. Carmeliet, Angiogenesis in life, disease and medicine. Nature 438, 932-936 (2005).
41. M. Rao, N. Chinnasamy, J. A. Hong, Y. Zhang, M. Zhang, S. Xi, F. Liu, V. E. Marquez, R. A. Morgan, D. S. Schrump, Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: Implications for adoptive immunotherapy of cancer. Cancer Res. 71, 4192-4204 (2011).
42. A. J. Singh, R. D. Meyer, G. Navruzbekov, R. Shelke, L. Duan, H. Band, S. E. Leeman, N. Rahimi, A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCγ1 activation and angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 104, 5413-5418 (2007).
43. R. D. Meyer, A. Singh, F. Majnoun, C. Latz, K. Lashkari, N. Rahimi, Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation. Oncogene 23, 5523-5531 (2004).
44. A. J. Singh, R. D. Meyer, H. Band, N. Rahimi, The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation. Mol. Biol. Cell 16, 2106-2118 (2005).